bpc-157 fda approval Big news for the peptide space., The Pharmacy Compounding Advisory Committee recently voted eight to six in favor of allowing compounding pharmacies to produce BPC 157. Here is what you need to FDA panel votes to ease

BMJ Best Practice

arguments against the use of oral cobalamin Oral treatment may be considered in certain situationsfor example, in mild or subclinical deficiency with no clinical features and when absorption and compliance are definitely not a problem

Rosen, M

Important Information Before Use PDA (BPC-157-Arginine) has not been adequately studied during pregnancy or breastfeeding and should only be considered under the guidance of a qualified healthcare provider

The long answer is that while research is limited, health experts say alcoholic beverages pose some theoretical health risks to people on GLP-1 drugs and in general, imbibing may interfere with your health and weight loss goals